Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome.

× No keyword cloud information.

25 in total

1. Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men.

Authors: Y M Fan; R Laaksonen; T Janatuinen; R Vesalainen; P Nuutila; J Knuuti; T Lehtimäki
Journal: Clin Genet Date: 2001-10 Impact factor: 4.438

2. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.

Authors: M Matsuda; B S Korn; R E Hammer; Y A Moon; R Komuro; J D Horton; J L Goldstein; M S Brown; I Shimomura
Journal: Genes Dev Date: 2001-05-15 Impact factor: 11.361

3. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors: Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal: Am J Hum Genet Date: 2003-12-15 Impact factor: 11.025

4. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background.

Authors: Sei-Ichiro Kojima; Norihito Watanabe; Makoto Numata; Tetsuhei Ogawa; Shohei Matsuzaki
Journal: J Gastroenterol Date: 2003 Impact factor: 7.527

5. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Authors: Ayako Suzuki; Keith Lindor; Jenny St Saver; James Lymp; Flavia Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Journal: J Hepatol Date: 2005-07-11 Impact factor: 25.083

6. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.

Authors: Min De Zeng; Jian Gao Fan; Lun Gen Lu; You Ming Li; Cheng Wei Chen; Bing Yuan Wang; Yi Min Mao
Journal: J Dig Dis Date: 2008-05 Impact factor: 2.325

Review 7. Dyslipidemia in patients with nonalcoholic fatty liver disease.

Authors: Hemant Chatrath; Raj Vuppalanchi; Naga Chalasani
Journal: Semin Liver Dis Date: 2012-03-13 Impact factor: 6.115

Review 8. Metabolic syndrome and non-alcoholic fatty liver disease.

Authors: Paloma Almeda-Valdés; Daniel Cuevas-Ramos; Carlos Alberto Aguilar-Salinas
Journal: Ann Hepatol Date: 2009 Impact factor: 2.400

Review 9. Nonalcoholic fatty liver disease.

Authors: M C Hjelkrem; D M Torres; S A Harrison
Journal: Minerva Med Date: 2008-12 Impact factor: 4.806

10. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors: K H Buetow; M Edmonson; R MacDonald; R Clifford; P Yip; J Kelley; D P Little; R Strausberg; H Koester; C R Cantor; A Braun
Journal: Proc Natl Acad Sci U S A Date: 2001-01-02 Impact factor: 11.205

4 in total

Review 1. The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors: Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal: J Clin Exp Hepatol Date: 2015-02-16

SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome.